Best Clinics and Costs for Pediatric Oncology in Spain 2025

Dr. Graupera is an awarded pediatric oncologist, one of the best bone and soft tissue sarcoma doctors. Heads the Hematology Oncology Department in Sant Joan De Déu — one of the best children’s hospitals in Europe. Researcher. Was trained in the USA. Specialty Provides treatments of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. Work experience Scientific Director of the Hematology Oncology Department in Sant Joan De Déu — Barcelona Children’s Hospital Director of the Developmental Tumors Laboratory in Sant Joan De Déu — Barcelona Children’s Hospital. Education 1990 — The Faculty of Medicine and Health Sciences at the University of Barcelona — Degree in general medicine and surgery 1995 — The Vall d'Hebron University Hospital — Specialty in pediatrics 1996-1999 — Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (USA) — Fellowship in pediatric hematology oncology 1999-2001 — Memorial Sloan Kettering Cancer Center (USA) — Fellowship in molecular pathology of pediatric cancer 2003 — The Autonomous University of Barcelona — PhD in Medicine. Awards 2000 — The Young Investigator Award by the American Society of Clinical Oncology 2001 — The Schweisguth Prize by the International Society of Pediatric Oncology for the best scientific article in pediatric oncology 2001 — The Career Development Award by the American Society of Clinical Oncology 2006 — The First Prize of the Spanish Association Against Cancer (AECC) award for the study of cancer in children 2011 — BBVA Foundation Award for the significant contributions in scientific research of pediatric cancer 2001 — The Schweisguth Prize by the International Society of Pediatric Oncology for the best scientific article in pediatric oncology. Scientific activity Dr. Jaume Mora Graupera has written over 70 papers on the malignant tumors treatment in children. Has developed a passive treatment for the spinal cord gliomas without radiation therapy. Membership in organizations The International Society of Pediatric Oncology (SIOP) The American Society of Clinical Oncology The American Association for Cancer Research The Spanish Society of Paediatric Hematology and Oncology The Catalan Society of Pediatrics The Histiocyte Society.

Dr. Andres E. Morales La Madrid has an extensive background in pediatric oncology with a range of specializations, including Pediatric Hematology & Oncology, Pediatric Neuro Oncology, and Cell Transplantation in Pediatrics. He has contributed significantly to medical research with numerous publications and is currently leading several research projects, particularly in the area of immunotherapy for diffuse intrinsic pontine glioma.EducationMedicine Degree, Universidad Peruana Cayetano Heredia - 2002Pediatrics Specialization, Vall Hebron Hospital - 2007Sub Specialty in Oncology, Hematology, and Cell Transplantation in Pediatrics, University of Chicago - 2012Sub Specialty in Pediatric Neuro Oncology, Harvard University - 2013Master in Hospital Management and Health Resources, University of Barcelona - 2018Publications"Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center" - EJC Paediatric Oncology, 2023"EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping" - iScience, 2023"Systematic review and practical example for 3D printing in surgical planning and training in pediatric endoscopic skull base surgery" - INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2023Research Projects"GLIOMATCH_The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics" - Funded by the European Commission, 2024 - 2028Clinical trial on the safety and feasibility of cellular immunotherapy for patients with DIPG - Funded by Instituto de Salud Carlos III (ISCIII), 2024 - 2027Research group project on developmental tumors - Funded by Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca, 2022 - 2025

Key facts and achievements - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases. -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care. - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris. Specialization More than 7,000 patients have been treated in the Radiosurgery Department, including: - Benign tumors : meningiomas, schwannomas, pituitary adenomas. - Malignant pathologies : brain metastases and CNS tumors. - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas. - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder. Scientific and professional activities - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh . - Author of scientific research and protocols for the treatment of cancer using radiotherapy. - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research. Experience 2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital. 2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital. 2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid Qualification 2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain 2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000. 1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain. 2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital. 1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases" 1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy" 1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer" 1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez. Teaching : 2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid. 2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons. 2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology. 2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid. 2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed. 2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University. 1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians). Publications 2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256. 2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047 2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203. 2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108. 2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15. Presentations 2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019. 2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018 2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid. 2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia 2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology. Communities it belongs to: -SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer) -SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector" -SSRI, International Society for Stereotactic Radiosurgery - Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC). Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.